List of companies in venBio's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
It is a biotech company that specializes in the development of drugs for the treatment of hypertension and other cardiovascular diseases. | ||||||
Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products. | ||||||
Harmony Biosciences is a private biopharmaceutical company that develops and commercializes novel treatment options. | ||||||
A histopathology company that provides specimen processing and pathology consultation, develops assays and is building a histology database for collaboration and crowdsourcing in the biomedical research community. | ||||||
Apellis Pharmaceuticals is a biotechnology research company developing drug delivery technologies and therapeutics for the treatment of chronic inflammatory diseases. | ||||||
Aurinia Pharmaceuticals is an Edmonton-based company developing therapies to treat patient populations suffering from disease states. | ||||||
ALX Oncology is a Burlingame, California-based biotechnology company working on pre-clinical stage immuno-oncology therapies. | ||||||
Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders. | ||||||
A clinical late-stage biopharmaceutical company in California that focuses on treatments of dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. | ||||||
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients. | ||||||
Turning Point Therapeutics, Inc. is a clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies | ||||||
Adaptimmune is a biotechnology company focused on the development of cancer immunotherapy products. | ||||||
Akero Therapeutics is a Cambridge, Massachusetts-based biotechnology company focused on reversing the NASH epidemic by restoring the body's metabolism to a balanced state. | ||||||
Checkmate Pharmaceuticals is a Cambridge, Massachusetts-based biopharmaceutical company focused on the activation of the innate immune system to treat cancer. The company was acquired by Regeneron in May 2022. | ||||||
Metacrine is a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal (GI) and liver diseases. | ||||||
Pharvaris is a Zug-based company focused on the development of oral bradykinin-B2-receptor antagonists. | ||||||
Operator of a biotechnology company intended to improve outcomes for people with cancer. The company offers a pipeline against validated oncology targets to deliver radioisotopes that emit alpha particles, enabling healthcare providers to improve the cancer patient's survival chances. | ||||||
Elevation Oncology is an oncology Company founded by Shawn M. Leland. | ||||||
Artiva Biotherapeutics is a NK Cell Therapies for Cancer founded in 2019. | ||||||
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable. | ||||||
Cidara Therapeutics is a biotechnology company. | ||||||
Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases | ||||||
Vyne Therapeutics is a small Molecule. | ||||||
Amyloidosis Treatments |
